Benztropine in the Treatment of Venlafaxine-Induced Sweating

View This PDF

NB: This article is only available as a PDF.

Letter to the Editor

Sir: Sweating is a relatively common side effect seen with serotonin selective reuptake inhibitors (SSRIs) and has been reported in 7% to 11% of patients treated with SSRIs and 12% of patients treated with venlafaxine, an antidepressant with the ability to inhibit the reuptake of serotonin and norepinephrine. The following case indicates that this side effect can cause severe social disruption and limit effective treatment of depression. A possible management strategy is also suggested.

J Clin Psychiatry 1997;58(4):176-177 [letter]